Amgen price target raised to $375 from $325 at Wells Fargo

Wells Fargo raised the firm’s price target on Amgen (AMGN) to $375 from $325 and keeps an Equal Weight rating on the shares. The firm is updating its model to reflect 10-K financial updates and adding additional Phase 3 pipeline asset value to its price target